Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Robert D. Dick"'
Autor:
Mohamed K. Khan, Meredith W. Miller, Jeremy Taylor, Navkiranjit K. Gill, Robert D. Dick, Kenneth Van Goled, George J. Brewert, Sofia D. Merajver
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 4, Iss 2, Pp 164-170 (2002)
Tetrathiomolybdate (TM) is a potent nontoxic orally delivered copper complexing agent under development for the last several years for the treatment of Wilson's disease. It has been shown to block angiogenesis in primary and metastatic tumors. Theref
Externí odkaz:
https://doaj.org/article/bbaa1a5cde434259a7fc41c3b9f31321
Autor:
Meredith Miller, Mohamed K. Khan, Jeremy M. G. Taylor, Robert D. Dick, George J. Brewert, Navkiranjit K. Gill, Sofia D. Merajver, Kenneth Van Goled
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 4, Iss 2, Pp 164-170 (2002)
Tetrathiomolybdate (TM) is a potent nontoxic orally delivered copper complexing agent under development for the last several years for the treatment of Wilson's disease. It has been shown to block angiogenesis in primary and metastatic tumors. Theref
Autor:
George J. Brewer, Robert D. Dick, Sofia D. Merajver, Marty Barrios, Theodoros N. Teknos, Claudell Cox
Publikováno v:
The Laryngoscope. 111:696-701
Objective To determine whether tetrathiomolybdate (TM), a powerful chelator of copper, is capable of lowering the body stores of copper and suppressing the growth of head and neck squamous cell carcinoma in an orthotopic murine model. Study Design In
Autor:
James A. Brunberg, Virginia Johnson, John K. Fink, George J. Brewer, Robert D. Dick, Karen J. Kluin
Publikováno v:
Journal of Laboratory and Clinical Medicine. 132:264-278
Wilson's disease is an inherited disease of copper accumulation caused by a failure of biliary excretion of excess copper. Accumulated copper causes liver disease in these patients, and in perhaps two thirds of patients, it causes brain damage leadin
Publikováno v:
The American Journal of the Medical Sciences. 305:199-202
A considerable body of data is now available indicating the efficacy and lack of toxicity of zinc treatment of Wilson's disease. Dose-response studies have shown that regimens of 50 mg of elemental zinc 3 times a day (50 mg x 3), 25 mg x 3, and 50 mg
Autor:
Roberta M. Tankanow, Vilma Yuzbasiyan-Gurkin, George J. Brewer, Robert D. Dick, Anne B. Young, Karen J. Kluin
Publikováno v:
Archives of Neurology. 48:42-47
Patients with Wilson's disease who present with acute neurological symptoms often become clinically worse when initially treated with penicillamine. Other available anticopper drug therapies do not appear to offer a solution to this treatment problem
Publikováno v:
Investigative ophthalmologyvisual science. 46(1)
To determine the effects of tetrathiomolybdate (TM), a copper-chelating agent, on retinal angiogenesis and vascular endothelial growth factor (VEGF) in a mouse model of retinal neovascularization.Postnatal day (P)7 C57BL/6N mice were exposed to 75% +
Autor:
Cisca Wijmenga, Colin S. Duckett, George J. Brewer, Lakshmanan Ganesh, Ezra Burstein, Robert D. Dick, Gary J. Nabel, Leo W. J. Klomp, Bart van de Sluis, John C. Wilkinson
Publikováno v:
The EMBO Journal, 23(1), 244-254. Wiley
XIAP is a potent suppressor of apoptosis that directly inhibits specific members of the caspase family of cysteine proteases. Here we demonstrate a novel role for XIAP in the control of intracellular copper levels. XIAP was found to interact with MUR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30a0858129ffccc7ad0b46a165d9e7e3
https://research.rug.nl/en/publications/91a71ab5-bd90-494a-adf7-d3bc926f74b9
https://research.rug.nl/en/publications/91a71ab5-bd90-494a-adf7-d3bc926f74b9
Publikováno v:
The Journal of laboratory and clinical medicine. 142(6)
We have treated 9 patients who presented with hepatic decompensation resulting from Wilson's disease with a combination of trientine and zinc, generally for at least 4 months, followed by transition to zinc maintenance therapy. All of these patients
Autor:
Robert D. Dick, George J. Brewer, Claudell Cox, Sofia D. Merajver, J. Lee, Theodoros N. Teknos, Sirius Yoo
Publikováno v:
Archives of otolaryngology--headneck surgery. 129(7)
Objective: To determine whether long-term therapy with tetrathiomolybdate suppresses tumor growth in an animal model. Design: In vivo murine model. Subjects: Thirteen 8-week-old C3H/HeJ mice, randomly assigned to a tetrathiomolybdate treatment group